Monday, July 15, 2024

CATEGORY

Eli Lilly

Alzheimer’s Treatment Advance: FDA Approves Lilly’s Kisunla for Early Symptomatic Stages

Alzheimer’s disease treatment has advanced with the U.S. Food and Drug Administration’s (FDA) approval of Eli Lilly’s Kisunla (donanemab-azbt, 350 mg/20 mL once-monthly injection...

Geographic Atrophy Treatments Face Setbacks as EU Drug Regulator Rejects Apellis’ Syfovre Again

For the second time in six months, the European Medicines Agency's (EMA) European Committee for Medicinal Products for Human Use (CHMP) has rejected Apellis’...

Resistant Bacteria Targeted in New Eli Lilly and OpenAI Collaboration to Discover Antimicrobials

Resistant bacteria are the focus of a groundbreaking collaboration between Eli Lilly and Company and OpenAI, which aims to leverage generative artificial intelligence (AI)...

Thyroid Cancer Treatment Advances: FDA Approves Selpercatinib for RET Fusion-Positive Cases

Thyroid cancer treatment has advanced as the Food and Drug Administration (FDA) grants traditional approval to selpercatinib (Retevmo, Eli Lilly) for treating adult and...

Alzheimer’s Disease Drug Donanemab to be Reviewed by FDA Advisory Committee for Early Treatment Approval

Alzheimer's drug donanemab developed by Eli Lilly will be discussed by the Peripheral and Central Nervous System Drugs Advisory Committee of the US Food...

Consumer Market Entry: Can Pfizer and Lilly Succeed in Direct-to-Consumer Sales?

Consumer market trends show that direct-to-consumer (DTC) platforms are becoming an increasingly popular method for consumers to access medications online, bypassing traditional in-person doctor...

Pediatric Cancers: Lilly’s Retevmo Approved for Treating RET-Positive Pediatric Cancers

Pediatric cancers have led the US Food and Drug Administration (FDA) to grant accelerated approval for Eli Lilly’s RET inhibitor, Retevmo (selpercatinib), as a...

A Breakthrough in Alzheimer’s Disease Diagnosis: Roche and Eli Lilly’s pTau217 Plasma Biomarker Test

The recent announcement from the U.S. Food and Drug Administration (FDA) bestowing breakthrough status upon the collaborative effort of Roche and Eli Lilly marks...

Eli Lilly’s Diabetes Medication Mounjaro Faces Extended Shortages Amid Surging Demand

In a recent announcement by the U.S. Food and Drug Administration (FDA), it has come to light that Eli Lilly’s diabetes medication, Mounjaro, is...

Lilly Introduces LillyDirect Telehealth Services for Obesity and Additional Medications

Eli Lilly, a prominent pharmaceutical company, has recently introduced a new website-based access program called LillyDirect, marking a significant shift in the way certain...

Latest news